These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


436 related items for PubMed ID: 14962562

  • 1. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.
    Dong Y, Feng SS.
    Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562
    [Abstract] [Full Text] [Related]

  • 2. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
    Dong Y, Feng SS.
    J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
    [Abstract] [Full Text] [Related]

  • 3. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z, Feng SS.
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [Abstract] [Full Text] [Related]

  • 4. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A, Voulgari E, Diamanti EK, Gournis D, Avgoustakis K.
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [Abstract] [Full Text] [Related]

  • 5. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z, Feng SS.
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
    Ruan G, Feng SS.
    Biomaterials; 2003 Dec; 24(27):5037-44. PubMed ID: 14559017
    [Abstract] [Full Text] [Related]

  • 7. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.
    Park EK, Lee SB, Lee YM.
    Biomaterials; 2005 Mar; 26(9):1053-61. PubMed ID: 15369694
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate.
    Zhang X, Li Y, Chen X, Wang X, Xu X, Liang Q, Hu J, Jing X.
    Biomaterials; 2005 May; 26(14):2121-8. PubMed ID: 15576187
    [Abstract] [Full Text] [Related]

  • 9. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
    Hu Y, Xie J, Tong YW, Wang CH.
    J Control Release; 2007 Mar 12; 118(1):7-17. PubMed ID: 17241684
    [Abstract] [Full Text] [Related]

  • 10. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
    Pan J, Feng SS.
    Biomaterials; 2008 Jun 12; 29(17):2663-72. PubMed ID: 18396333
    [Abstract] [Full Text] [Related]

  • 11. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.
    Ouahab A, Shao C, Shen Y, Tu J.
    Drug Dev Ind Pharm; 2014 Jul 12; 40(7):860-8. PubMed ID: 23600653
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and drug release behavior of poly (trimethylene carbonate)-poly (ethylene glycol)-poly (trimethylene carbonate) nanoparticles.
    Zhang Y, Zhuo RX.
    Biomaterials; 2005 May 12; 26(14):2089-94. PubMed ID: 15576183
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J, Feng SS, Wang S, Chen ZY.
    Int J Pharm; 2010 Nov 15; 400(1-2):194-200. PubMed ID: 20801205
    [Abstract] [Full Text] [Related]

  • 16. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
    Essa S, Rabanel JM, Hildgen P.
    Eur J Pharm Biopharm; 2010 Jun 15; 75(2):96-106. PubMed ID: 20211727
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy.
    Zhang Z, Feng SS.
    Biomacromolecules; 2006 Apr 15; 7(4):1139-46. PubMed ID: 16602731
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Controlled drug release system based on cyclodextrin-conjugated poly(lactic acid)-b-poly(ethylene glycol) micelles.
    He Q, Wu W, Xiu K, Zhang Q, Xu F, Li J.
    Int J Pharm; 2013 Feb 25; 443(1-2):110-9. PubMed ID: 23328682
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.